Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JUNS
JUNS logo

JUNS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jupiter Neurosciences Inc (JUNS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.360
1 Day change
-5.79%
52 Week Range
3.330
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Jupiter Neurosciences Inc (JUNS) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks positive momentum, has no significant trading signals, and displays weak financial performance. Given the absence of positive catalysts and the bearish technical indicators, it is better to hold off on investing in this stock at the moment.

Technical Analysis

The MACD is slightly positive but contracting, RSI is neutral at 30.416, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 0.344, with resistance at 0.428. The stock has a 70% chance to decline by -2.38% in the next day, -4.84% in the next week, and -7.84% in the next month.

Positive Catalysts

  • NULL identified. No recent news or significant insider or hedge fund activity.

Neutral/Negative Catalysts

  • Bearish technical indicators, weak financial performance, and a high probability of short-term price decline.

Financial Performance

In Q3 2025, revenue remained at 0 with no YoY growth. Net income improved to -$2,288,034 (up 287.13% YoY), and EPS increased to -0.07 (up 250% YoY). However, the company remains unprofitable with no gross margin.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available.

Wall Street analysts forecast JUNS stock price to rise
1 Analyst Rating
Wall Street analysts forecast JUNS stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.380
sliders
Low
25
Averages
25
High
25
Current: 0.380
sliders
Low
25
Averages
25
High
25
Greenridge
William Gregozeski
Buy
downgrade
$30 -> $25
AI Analysis
2025-11-05
Reason
Greenridge
William Gregozeski
Price Target
$30 -> $25
AI Analysis
2025-11-05
downgrade
Buy
Reason
Greenridge analyst William Gregozeski lowered the firm's price target on Jupiter Neurosciences to $25 from $30 and keeps a Buy rating on the shares after the company announced last week that it entered into a $20M Standby Equity Purchase Agreement with Yorkville Advisors. The firm added in the cash and dilutive impact from the initial $6M advance and is assuming the notes are repaid with stock at $1.50 per share, the analyst noted.

People Also Watch